Skip to content
10-K

Annual Report

BIODESIX INC BDSX

0001193125-26-076547

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 9.86M sh
Shares Diluted FY 2025 · Dec 31, 2025 7.55M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 6.47M sh
Capex FY 2025 · Dec 31, 2025 $259K
Capex FY 2025 · Dec 31, 2024 $3.23M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$23.27M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$48.65M
Long Term Debt FY 2025 · Dec 31, 2025 $50.01M
Cash And Equivalents FY 2025 · Dec 31, 2025 $18.99M
Cash And Equivalents FY 2025 · Dec 31, 2024 $26.25M
Stockholders Equity FY 2025 · Dec 31, 2025 −$2.47M
Stockholders Equity FY 2025 · Dec 31, 2024 $20.88M
Stockholders Equity FY 2025 · Dec 31, 2023 $4.58M
Current Liabilities FY 2025 · Dec 31, 2025 $17.44M
Current Liabilities FY 2025 · Dec 31, 2024 $14.32M
Total Liabilities FY 2025 · Dec 31, 2025 $89.94M
Total Liabilities FY 2025 · Dec 31, 2024 $76.37M
Current Assets FY 2025 · Dec 31, 2025 $32.52M
Current Assets FY 2025 · Dec 31, 2024 $39.48M
Total Assets FY 2025 · Dec 31, 2025 $87.48M
Total Assets FY 2025 · Dec 31, 2024 $97.24M
Eps Diluted FY 2025 · Dec 31, 2025 −$4.67
Eps Diluted restated FY 2025 · Dec 31, 2024 −$6.64
Eps Basic FY 2025 · Dec 31, 2025 −$4.67
Eps Basic restated FY 2025 · Dec 31, 2024 −$6.64
Sga Expense FY 2025 · Dec 31, 2025 $87.55M
Sga Expense FY 2025 · Dec 31, 2024 $80.45M
Rd Expense FY 2025 · Dec 31, 2025 $12M
Rd Expense FY 2025 · Dec 31, 2024 $9.56M
Net Income FY 2025 · Dec 31, 2025 −$35.27M
Net Income FY 2025 · Dec 31, 2024 −$42.93M
Operating Income FY 2025 · Dec 31, 2025 −$27.87M
Operating Income FY 2025 · Dec 31, 2024 −$34.5M
Revenue FY 2025 · Dec 31, 2025 $88.5M
Revenue FY 2025 · Dec 31, 2024 $71.32M